About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 614 record(s)
Req # A-2022-000751
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108092-418.Organization: Health Canada
February 2024
Req # A-2022-000779
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075262-896, Follow Up to 2019 National Indigenous Economic Development Board Progress Report Recommendations.Organization: Health Canada
February 2024
Req # A-2022-001539
Adverse Drug Reactions (ADRs). Report numbers: E2B_04042181, E2B_04048665, E2B_04073680, 000958710, 000962869, E2B_04099030, E2B_04186572, E2B_04198568, E2B_04208689, E2B_04238483.Organization: Health Canada
February 2024
Req # A-2023-000288
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-102433-804.Organization: Health Canada
February 2024
Req # A-2023-000298
Adverse Drug Reactions (ADRs). Report numbers: E2B_03285800, E2B_03287788, E2B_03320920, E2B_03322027, E2B_03374289, E2B_03394199, E2B_03398583, E2B_03444507, E2B_03304752, E2B_03309177.Organization: Health Canada
February 2024
Req # A-2023-000411
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-106730-677.Organization: Health Canada
February 2024
Req # A-2023-000526
Adverse Drug Reactions (ADRs) for . Report numbers: E2B_06360048, E2B_06366202, E2B_06381631, E2B_06381632, E2B_06381974, E2B_06390656, E2B_06400444, E2B_06406461. ADRs for SUCROFERRIC OXYHYDROXIDE. Report numbers: E2B_06368342, E2B_06378393.Organization: Health Canada
February 2024
Req # A-2023-000630
Adverse Drug Reactions (ADRs) for AMPHETAMINE ASPARTATE MONOHYDRATE/AMPHETAMINE SULFATE/DEXTROAMPHETAMINE SACCHARATE/ DEXTROAMPHETAMINE SULFATE. Report numbers: 001040668, E2B_06395423. ADRs for MESALAMINE. Report numbers: E2B_06369931, E2B_06341301…Organization: Health Canada
February 2024
Req # A-2023-000642
Adverse Drug Reactions (ADRs). Report numbers: E2B_06380669, E2B_06391938, E2B_06347544, E2B_06389442, 001039604, 001039011, E2B_06359710, E2B_06400511, E2B_06353100, E2B_06228427.Organization: Health Canada
February 2024
Req # A-2023-000704
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-105579-25.Organization: Health Canada
February 2024